Liestal, Switzerland

Hans Steffen

USPTO Granted Patents = 13 


Average Co-Inventor Count = 2.7

ph-index = 11

Forward Citations = 1,494(Granted Patents)


Location History:

  • Arisdorf, CH (1979 - 1987)
  • Liestal, CH (1989 - 2011)

Company Filing History:


Years Active: 1979-2011

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovations of Hans Steffen

Introduction

Hans Steffen is a notable inventor based in Liestal, Switzerland. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work focuses on developing innovative pharmaceutical compositions that enhance drug efficacy and absorption.

Latest Patents

Among his latest patents, one includes pharmaceutical compositions containing lipase inhibitors. This composition comprises at least one inhibitor of lipases, preferably targeting gastrointestinal and pancreatic lipases, such as orlistat, along with at least one surfactant and one dispersant. Another notable patent involves pharmaceutical compositions that have depressed melting points. This invention relates to compositions containing a solid pharmaceutically active compound with a melting point of 37°C or higher, combined with a fatty acid or a fatty acid salt. This composition results in a depression in melting point to 37°C or lower upon contact with an aqueous solution, thereby improving absorption.

Career Highlights

Hans Steffen has built a successful career at Hoffmann-La Roche Inc., where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have led to the creation of effective therapeutic solutions that address various health issues.

Collaborations

Throughout his career, Hans has collaborated with esteemed colleagues, including Paul Hadvary and Hans Lengsfeld. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Hans Steffen's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through science. His patents reflect a deep understanding of drug formulation and a dedication to enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…